Table 2.
Results of all tests.
Inspection antibody | Abbreviation | Test date | Reference range | Units | Test method | ||||
---|---|---|---|---|---|---|---|---|---|
08/05.2021 | 09/06.2021 | 11/12.2021 | 03/07.2022 | 01/15.2023 | |||||
Perinuclear Anti-neutrophil cytoplasmic antibody | pANCA | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | IF |
Cytoplasmic Anti-neutrophil cytoplasmic antibody | cANCA | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | IF |
Anti-protease 3 antibody | PR3-Ab | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB |
Anti-myeloperoxidase antibody | MPO-Ab | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB |
Anti-glomerular basement membrane antibody | GBM | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | ELISA |
Immunoglobulin G4 | G4 | 311.8 | N/A | N/A | N/A | N/A | 39.2–864.0 | mg/L | IT |
Anti-β2 glycoprotein 1IgA antibody | β2 GPI-IgA | 3.75 | N/A | N/A | < 2.00 | N/A | < 20.00 | RU/mL | CL |
Anti-β2 glycoprotein 1IgM antibody | β2 GPI-IgM | 5.29 | N/A | N/A | 2.61 | N/A | < 20.00 | RU/mL | CL |
Anti-β2 glycoprotein 1IgG antibody | β2 GPI-IgG | < 2.00 | N/A | N/A | < 2.00 | N/A | < 20.00 | RU/mlL | CL |
Anti-cardiolipin IgG antibody | ACL-IgG | < 2.00 | N/A | N/A | < 2.00 | N/A | < 20.00 | RU/mL | CL |
Anticardiolipin IgA antibody | ACL-IgA | < 2.00 | N/A | N/A | < 2.00 | N/A | < 20.00 | RU/mL | CL |
Anti-cardiolipin IgM antibody | ACL-IgM | 6.37 | N/A | N/A | 4.11 | N/A | < 20.00 | RU/mL | CL |
Melanoma differentiation-associated gene 5 antibody | anti-MDA5 | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | CBA |
Anti-OJ antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-KS antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-ZO antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-HA antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-Scl-70 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-PM-SCL100 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-PM-SCL75 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-KU antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-RNA-PIII antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-Th/To antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-Fibrillarin antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-NOR-90 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-JO-1 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-PL-7 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-PL-12 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-EJ antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-SRP antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-Mi-2 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-TIF1γ antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-Ro-52 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-SAE1 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-SAE2 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-NXP2 antibody | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | WB | |
Anti-phosphatidylserine/prothrombin IgG antibody | aPS/PT | 3.37 | N/A | N/A | 8.29 | N/A | 0.00–30.00 | U/mL | ELISA |
Anti-double-stranded DNA antibody | dsDNA | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | ELISA |
Acetylcholine receptor antibody | AchR.Ab | < 0.01 | N/A | N/A | N/A | N/A | < 0.45 | nmol/L | ELISA |
Muscle-specific tyrosine kinase antibody | MuSK.Ab | 0.25 | N/A | N/A | N/A | N/A | < 0.40 | U/mL | ELISA |
Titin antibody | Titin-Ab | 0.01 | N/A | N/A | N/A | N/A | < 15.00 | U/mL | ELISA |
Ryanodine receptor antibody | RyR.Ab | Negative (−) | N/A | N/A | N/A | N/A | Negative (−) | N/A | ELISA |
Anti-glutamate receptor (NMDA type) IgG antibody | Anti-NMDA | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | CBA |
Anti-glutamate Receptor AMPA1 IgG antibody | Anti-AMPA1 | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | CBA |
Anti-glutamate receptor AMPA2 IgG antibody | Anti-AMPA2 | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | CBA |
Anti-gamma-aminobutyric acid Type B Receptor IgG antibody | Anti-GABA B | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | CBA |
Anti-GM1 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM2 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM3 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM4 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD1a antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD1b antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD2 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD3 antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GT1a antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GT1b antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GQ1b antibody IgG | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-Sulfatide antibody IgM | Sulf | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB |
Anti-GM1 antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM2 antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM3 antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GM4 antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD1a antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD1b antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GD3 antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GT1a antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GT1b antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Anti-GQ1b antibody IgM | Negative (−) | Negative (−) | Negative (−) | Negative (−) | N/A | Negative (−) | N/A | WB | |
Complement C3 | C3 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Complement C4 | C4 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Immunoglobulin A | IgA | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Immunoglobulin G | IgG | Feminine (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Immunoglobulin M | IgM | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti- PM-SCL antibody | Anti-PM | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-polymyositis antibody | Anti-Jo1 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-sjogren Syndrome A | Anti-SSA | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-sjogren Syndrome B | Anti-SSB | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-sjogren Syndrome Ro52 | Anti-Ro52 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Antinuclear antibody | ANA-IIF | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | IF |
Anti-nuclear karyotype 1 titer | ANA-T1D | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-ribonucleoprotein antibody | Anti-RNP | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-ribosome P protein antibody | Anti-rib | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-nucleosome antibody | ANuA | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-acid nucleoprotein | Anti-Sm | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti- double-stranded DNA | Anti-dSDNA | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-systemic sclerosis antibody | Anti-Sc1 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-cyclin antibody | Anti-PCNA | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-mitochondrial M2 antibody | AMA M2 | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-centromere B antibody | Anti-cenPb | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Anti-histone antibody | Anti-His | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
Rheumatoid factors | RF | Negative (−) | N/A | N/A | N/A | Negative (−) | Negative (−) | N/A | CL |
CBA = cell based fluorescence assay, CL = chemiluminescence assay, ELISA = enzyme-linked immunosorbent assay, IF = immunofluorescence staining assay, ISE = ion selective electrode method, IT = immunoturbidimetry assay, WB = western blotting analysis.